|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 31/4439 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) |
| (11) | Patento numeris | 3498734 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18205542.6 |
| Europos patento paraiškos padavimo data | 2015-02-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-06-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-09-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201461935809 P | 2014-02-04 | US |
| (72) |
MARTINI, Jean-Francais Andre , US
TARAZI, Jamal Christo , US
PERINI, Rodolfo Fleury , US
MAURO, David J. , US
|
| (73) |
Pfizer Inc. ,
235 East 42nd Street, New York, NY 10017,
US
Merck Sharp & Dohme Corp. , 126 East Lincoln Avenue, Rahway, NJ 07065, US |
| (54) | COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER |
| COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER |